Patients with rheumatoid arthritis (RA) who are treated successfully for their illness may also see a reduction in their cholesterol levels. Newly diagnosed RA patients tend to have adverse lipid profiles, ie, low levels of high-density lipoprotein and high levels of low-density lipoprotein.
Now researchers at Yonsei University College of Medicine in Seoul report that after a year, 64% of patients who had recently been diagnosed with RA responded positively to the same antirheumatic treatment?and that these same patients had improved lipid profiles, even though no lipid-lowering drugs were given.
?The results of the study suggest that lipid profiles can be improved by treating RA without the use of cholesterol-lowering drugs,? the researchers say. It is not clear why inflammation and lipid levels might be linked in RA patients, but the researchers plan further studies to investigate possible mechanisms.
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs